Back to Search
Start Over
[HDL-C/apoA-I]: A multivessel cardiometabolic risk marker in women with T2DM.
- Source :
-
Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2018 Jan; Vol. 34 (1). Date of Electronic Publication: 2017 Oct 16. - Publication Year :
- 2018
-
Abstract
- Aims: Although women have higher high-density lipoprotein cholesterol (HDL-C) than have men, their HDL particles are also prone to become small, dense, and dysfunctional in case of type 2 diabetes mellitus (T2DM). To assess the vascular risk related to HDLs of different sizes/densities without direct measurement, we adjusted HDL-C to its main apolipoprotein (apoA-I) as [HDL-C/apoA-I]. This ratio estimates HDL sizes and provides indices as to their number, cholesterol load, and density.<br />Methods: We stratified 280 Caucasian T2DM women according to [HDL-C/apoA-I] quartiles (Q) to determine how they are segregated according to cardiometabolic risk, β-cell function, glycaemic control, and vascular complications. Five parameters were derived from combined determination of HDL-C and apoA-I: HDL size, HDL number, cholesterol load per particle (pP), apoA-I pP, and HDL density.<br />Results: An adverse cardiometabolic profile characterized QI and QII patients whose HDLs were denser and depleted in apoA-I, whereas QIII patients had HDLs with characteristics closer to those of controls. QIV patients had HDLs of supernormal size/composition and a more favourable phenotype in terms of fat distribution; insulin sensitivity (64% vs 41%), metabolic syndrome, and β-cell function (32% vs 23%); exogenous insulin (44 vs 89 U·d <superscript>-1</superscript> ); and glycaemic control (glycated haemoglobin, 56 vs 61 mmol·mol <superscript>-1</superscript> ), associated with lower prevalence of microvascular/macrovascular complications: all-cause microangiopathy 47% vs 61%; retinopathy 22% vs 34%; all-cause macroangiopathy 19% vs 31%; and coronary artery disease 6% vs 24% (P < .05).<br />Conclusion: [HDL-C/apoA-I] can stratify T2DM women according to metabolic phenotype, macrovascular and coronary damage, β-cell function, microangiopathic risk, and retinopathy. This ratio is a versatile and readily available marker of cardiometabolic status and vascular complications in T2DM women.<br /> (Copyright © 2017 John Wiley & Sons, Ltd.)
- Subjects :
- Aged
Cardiovascular Diseases blood
Cardiovascular Diseases etiology
Female
Follow-Up Studies
Humans
Metabolic Diseases blood
Metabolic Diseases etiology
Prognosis
Retrospective Studies
Risk Factors
Apolipoprotein A-I blood
Biomarkers blood
Cardiovascular Diseases diagnosis
Cholesterol, HDL blood
Diabetes Mellitus, Type 2 complications
Metabolic Diseases diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1520-7560
- Volume :
- 34
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Diabetes/metabolism research and reviews
- Publication Type :
- Academic Journal
- Accession number :
- 28921828
- Full Text :
- https://doi.org/10.1002/dmrr.2950